LNTH Stock Analysis: Buy, Sell, or Hold?
LNTH - Lantheus Holdings, Inc
$74.47
-1.89 (-2.48%)
▼
5d:
-2.56%
30d:
-1.27%
90d:
+11.83%
BUY
MODERATE Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 06, 2026
Get Alerted When LNTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: LNTH shows positive signals but monitor for confirmation. Market pricing in 0.8% decline. Moderate conviction.
💡 BUY OPPORTUNITY: LNTH shows positive signals but monitor for confirmation. Market pricing in 0.8% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$136.82
Based on 12.6% avg growth
INTRINSIC VALUE TODAY
$84.95
12.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LNTH is currently trading at $74.47, which is considered fair relative to its 30-day fair value range of $73.60 to $79.83. The stock's valuation (Forward PE: 11.8) is in line with its historical norms (12.1). Remarkably, the market is currently pricing in an annual earnings decline of 0.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, LNTH is in a strong uptrend. The price is currently testing key support at $73.82. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $91.38 (+22.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LNTH is in a strong uptrend. The price is currently testing key support at $73.82. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $91.38 (+22.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$73.60 -
$79.83
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.7% below Wall St target ($91.38)
Fair Price Analysis
30-Day Fair Range
$73.60 -
$79.83
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$73.82
Resistance Level
$81.47
Current Trend
Strong Uptrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.83
Wall Street Target
$91.38
(+22.7%)
Revenue Growth (YoY)
4.0%
Earnings Growth (YoY)
-77.1%
Profit Margin
15.2%
Valuation Discount vs History
-0.8% cheaper
PE vs Historical
11.8 vs 12.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.8%
(market-implied from PE analysis)
1-Year Target
$73.87
(-1%)
2-Year Target
$73.28
(-2%)
3-Year Target
$72.70
(-2%)
3-Yr Target (if PE normalizes)
(PE: 12→12)
$74.33
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 21.2%)
$251.23
(+237%)
Base:
(SPY PE: 11.8, Growth: 21.2%)
$132.73
(+78%)
Bear:
(PE: 10.1, Growth: 21.2%)
$112.82
(+52%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 22.41 | Current EPS (TTM): $3.41
Bull Case
$155.15
(+105%)
Analyst growth 84.5%, PE expands to 24.7
Base Case
$141.04
(+86%)
Market implied 84.5%, PE stable at 22.4
Bear Case
$51.97
(-31%)
Severe decline -20.0%, PE contracts to 19.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.8 to 12.1
Stabilization Target:
$76.14
(+2.2%)
PE Expansion Potential:
+2.2%
Share & Embed Analysis
Last updated: March 30, 2026 7:02 AM ET
Data refreshes hourly during market hours. Next update: 8:02 AM
Data refreshes hourly during market hours. Next update: 8:02 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LNTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$178 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$151 | 55 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 60 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 58 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 58 HOLD |
